Veru Inc (VERU) Stock Price

2.34 ▲ +0.02 (+0.86%)
Open: 2.30 Vol: 97.84K Day's range: 2.25 - 2.35 Dec 24, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
VERU Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 2.33▲ 2.32▲ 2.31▲ 2.31▲ 2.41▼
MA10 2.32▲ 2.31▲ 2.32▲ 2.36▼ 2.61▼
MA20 2.31▲ 2.31▲ 2.31▲ 2.42▼ 3.12▼
MA50 2.31▲ 2.30▲ 2.31▲ 2.82▼ 1.60▲
MA100 2.31▲ 2.35▼ 2.42▼ 3.09▼ 1.22▲
MA200 2.29▲ 2.42▼ 2.44▼ 1.82▲ 3.43▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.004▲ 0.002▲ 0.004▲ 0.014▲ -0.199▼
RSI 57.218▲ 54.569▲ 54.622▲ 41.484▼ 49.210▼
STOCH 78.788     52.875     38.808     25.328     11.430▼
WILL %R 0.000▲ -42.105     -32.000     -67.925     -90.726▼
CCI 120.746▲ 60.528     108.130▲ -75.750     -68.975    
Latest Filters Detected On VERU
MA $VERU Price Crossed Above MA(7) Set Alert
Veru Inc News
Veru Inc. (NASDAQ: VERU) Q4 2025 earnings call transcript
Tuesday, December 23, 2025 05:01 AM
Q4 2025 Earnings Call Transcript December 17, 2025 Veru Inc. beats earnings expectations. Reported EPS is $0.05, expectations were $-0.39. Operator: Good morning, ladies and gentlemen, and welcome to ...
Why Veru Inc. Is Rising In Pre-market?
Tuesday, June 24, 2025 06:05 AM
(RTTNews) - Veru Inc. (VERU) announced positive topline efficacy and safety results from the maintenance extension portion of the Phase 2b QUALITY clinical study. The company said the Phase 2b ...
Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal ...
Wednesday, May 28, 2025 03:30 AM
--Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone-- --Based on Phase 2b QUALITY trial ...
VERU historical stock data
date open high low close volume
24/12/25 2.30 2.35 2.25 2.34 97,838
23/12/25 2.25 2.38 2.23 2.32 150,042
22/12/25 2.33 2.49 2.24 2.29 292,174
19/12/25 2.30 2.35 2.22 2.32 266,896
18/12/25 2.39 2.41 2.20 2.26 893,486
17/12/25 2.45 2.60 2.17 2.23 410,240
16/12/25 2.40 2.4494 2.335 2.44 141,290
15/12/25 2.46 2.56 2.38 2.39 73,112
12/12/25 2.54 2.63 2.42 2.42 97,158
11/12/25 2.54 2.56 2.47 2.56 77,286
Quote Details
52wk Low:0.364
52wk High:4.59
Vol:97.84K
Avg Vol(3m):3.4M
1Y Chng:+207.01%
1M Chng:-14.29%
Add to Watch List
More Information
Index US Composite
Market Cap. 37.56M